Clinical manifestations of COVID-19 in the general population: systematic review.
Clinical manifestations of COVID-19 in the general population: systematic review.
复制标题
DOI:
10.1007/s00508-020-01760-4
复制
发表时间:
2021-04
影响因子:
2.6
通讯作者:
Freire de Souza CD
中科院分区:
文献类型:
--
作者:
da Rosa Mesquita R;Francelino Silva Junior LC;Santos Santana FM;Farias de Oliveira T;Campos Alcântara R;Monteiro Arnozo G;Rodrigues da Silva Filho E;Galdino Dos Santos AG;Oliveira da Cunha EJ;Salgueiro de Aquino SH;Freire de Souza CD
Clinical manifestations of COVID-19 are varied in the general population. This study aimed to systematize the literature regarding clinical manifestations of patients with confirmed COVID-19. A systematic review of the literature was conducted. A total of 8070 scientific productions were found in the databases. Among the studies, 184 met the initial inclusion criteria, with a total of 114,046 patients. After complete reading, 32 studies that did not report clinical manifestations were excluded. The 152 publications finally included a total of 41,409 individuals from at least 23 countries and 26 different clinical manifestations were reported. In percentage terms, 6 symptoms had a general prevalence greater than or equal to 25%, namely, fever (58.66%), cough (54.52%), dyspnea (30.82%), malaise (29.75%), fatigue (28.16%) and sputum/secretion (25.33%). Neurological symptoms (20.82%), dermatological manifestations (20.45%), anorexia (20.26%), myalgia (16.9%), sneezing (14.71%), sore throat (14.41%), rhinitis (14.29%), goosebumps (13.49%), headache (12.17%), chest pain (11.49%) and diarrhea (9.59%) were other common symptoms. Only one study reported dermatological manifestations. The least frequent sign/symptom was hemoptysis (1.65%). In studies with more than 100 patients, the 3 main symptoms were fever (57.93%), cough (54.21%), and dyspnea (30.64%). Dermatological manifestations do not appear among the main symptoms. The identification of all clinical manifestations of COVID-19 is essential for an early diagnosis and the adoption of preventive measures. The online version of this article (10.1007/s00508-020-01760-4) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
3.9
作者:
Kinoshita R;Anzai A;Jung SM;Linton NM;Miyama T;Kobayashi T;Hayashi K;Suzuki A;Yang Y;Akhmetzhanov AR;Nishiura H
通讯作者:
Nishiura H
影响因子:
4.5
作者:
Shao, Siyao;Zhou, Dezhi;Hong, Jiarong
通讯作者:
Hong, Jiarong
影响因子:
13.6
作者:
通讯作者:
--
影响因子:
2.2
作者:
Dai W;Chen X;Xu X;Leng Z;Yu W;Lin H;Li H;Lin J;Qiu Z;Dai Y
通讯作者:
Dai Y
影响因子:
2.6
作者:
Vaira, Luigi A.;Salzano, Giovanni;De Riu, Giacomo
通讯作者:
De Riu, Giacomo